How long before a percutaneous endoscopic gastrostomy (PEG) procedure should aspirin be discontinued?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Aspirin Management Before PEG Procedure

Do not stop aspirin before PEG placement—aspirin should be continued throughout the procedure. 1

Key Recommendation

According to the 2021 BSG/ESGE guidelines, PEG is classified as a high-risk endoscopic procedure, but the management of aspirin depends critically on the patient's thrombotic risk profile, not the procedure risk alone 1.

For Patients on Aspirin Alone:

  • Continue aspirin regardless of thrombotic risk status
  • No interruption needed before PEG
  • This applies to both low and high thrombotic risk patients

For Patients on Dual Antiplatelet Therapy (DAPT):

The approach differs based on thrombotic risk:

High Thrombotic Risk (coronary stents, recent stroke/TIA, peripheral vascular disease):

  • Continue aspirin (strong recommendation, high quality evidence) 1
  • Consult interventional cardiology regarding P2Y12 inhibitor (clopidogrel, prasugrel, ticagrelor) management
  • If P2Y12 inhibitor must be stopped: discontinue 7 days before procedure 1
  • Restart P2Y12 inhibitor 1-2 days after procedure 1

Low Thrombotic Risk:

  • Continue aspirin (strong recommendation, low quality evidence) 1
  • Stop P2Y12 inhibitor 7 days before procedure (strong recommendation, moderate quality evidence) 1

Evidence Supporting Aspirin Continuation

The guideline recommendations are reinforced by research evidence:

  • A 2011 retrospective study of 990 PEG patients found no association between aspirin use (at any dose) and post-PEG bleeding 2
  • The same study found that clopidogrel was also not associated with bleeding risk 2
  • Interestingly, serotonin reuptake inhibitors (SRIs) were associated with 4-fold increased bleeding risk, not antiplatelet agents 2

A 2025 large database study confirmed these findings, showing no statistically significant difference in 7-day bleeding risk between patients on anticoagulants versus those not on anticoagulants, and no significant difference between DAPT and aspirin-only groups 3.

Clinical Algorithm

Step 1: Identify if patient is on aspirin

  • If yes → Continue aspirin

Step 2: Identify if patient is on DAPT (aspirin + P2Y12 inhibitor)

  • If yes → Proceed to Step 3
  • If no → No medication changes needed

Step 3: Assess thrombotic risk

  • High risk indicators:
    • Coronary stents (especially <6-12 months for drug-eluting, <1 month for bare metal)
    • Recent stroke/TIA
    • Ischemic heart disease
    • Peripheral vascular disease

Step 4: For high thrombotic risk

  • Continue aspirin
  • Mandatory cardiology consultation before stopping P2Y12 inhibitor
  • If approved to stop: discontinue 7 days pre-procedure, restart 1-2 days post-procedure

Step 5: For low thrombotic risk

  • Continue aspirin
  • Stop P2Y12 inhibitor 7 days before
  • Restart 1-2 days after procedure

Important Caveats

Post-Procedure Management:

  • Resume any discontinued antiplatelet therapy 2-3 days after PEG depending on bleeding and thrombotic risk assessment 1
  • Counsel patients about increased bleeding risk compared to those not on antiplatelets 1

Common Pitfall to Avoid:

Do not automatically stop aspirin because PEG is a "high-risk procedure." The 2021 guidelines explicitly state that aspirin continuation is recommended for high-risk procedures, with management decisions focused on P2Y12 inhibitors and anticoagulants, not aspirin 1.

Special Consideration:

If the patient is on aspirin for primary prevention only (no cardiovascular disease), consider discussing with the referring physician whether aspirin is truly indicated, as guidelines suggest permanent discontinuation may be appropriate in this specific scenario 1. However, for secondary prevention, aspirin must be continued.

Related Questions

How many days should low‑dose aspirin be stopped before percutaneous endoscopic gastrostomy (PEG) insertion?
Which of the following statements about aspirin is false? A) It irreversibly inhibits cyclooxygenase‑1. B) It has a proven benefit when administered to individuals with established cardiovascular disease. C) It increases the risk of gastrointestinal bleeding. D) Its antiplatelet effect lasts 7–10 days. E) Its administration at a dose of 75–100 mg daily is recommended for primary prevention in individuals at moderate cardiovascular risk.
According to the 2024 AHA/ACC guidelines, how many days before elective spine surgery should low‑dose aspirin be discontinued, and what are the recommendations for patients on aspirin for secondary prevention?
Following a prostate biopsy, when is it safe to restart aspirin (acetylsalicylic acid)?
What is the mechanism of action and pathophysiology of aspirin?
Are there any other medications to which this patient, who has a documented allergy to chickpeas, other legumes, and lentils, may be allergic?
What is lymphoma?
How many days should low‑dose aspirin be stopped before percutaneous endoscopic gastrostomy (PEG) insertion?
What are the common presenting symptoms of hypertension and the likely underlying diagnoses, including secondary causes?
What is the recommended treatment for autoimmune hemolytic anemia that is only partially responsive to corticosteroids?
How should I manage a woman with polycystic ovary syndrome who is not taking any medication and is experiencing prolonged uterine bleeding?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.